Abernathy MacGregor and Kekst are engaged in a proxy showdown over publicly traded nutritional supplement company Omega Protein Corp.
Houston-based Omega is facing a proxy contest from hedge fund Wynnefield Capital, which is offering two candidates for Omega's board. Wynnefield says it wants to "reverse the company's trajectory of capital loss."
The proxy contest has turned particularly sour late last week when Wynnefield sued Omega in Nevada state court to obtain shareholder information, a move dubbed a "blatant public relations effort to distract stockholers" by Omega.
Omega is working with Abernathy MacGregor, where executive VP Sydney Isaacs is advising Omega out of Houston. The company has also engaged D.F. King & Co. for proxy solicitation.
On the flip side, Wynnefield Capital is working with Kekst on the PR front. Kekst managing directors Mark Semer and Danniel Yunger are on the Wynnefield team.
Omega's annual meeting is set for June 28. First quarter revenues were up 18% to $84.8M with net income of $8.4M.
Interpublic posted a 5.1 percent drop in Q3 net revenues to $2.5B as CEO Philippe Krakowsky reports the final financial results of the publicly traded company.
Joele Frank handles Pine Gate Renewables as the Asheville, NC-based solar power development company declares Chapter 11 in the aftermath of Donald Trump’s cuts to wind & solar tax credits.
Stagwell CEO Mark Penn reports Q3 net revenues jumped 6 percent to $614.5M, a record performance for a non-political period. Operating income soared 45.7 percent to $60.9M.
Joele Frank works for Klöckner Pentaplast as the German maker of plastic films declares Chapter 11. A successful reorganization would slash its its corporate debt by $1.5B.
Teneo represents Metsera, the New York City biotech focused on weight-control products, which is subject to a bidding war between heavyweights Novo Nordisk and Pfizer.
